Role of alpha-terpineol modulating pathway nitric oxide into coronary tissues: A confluent mechanism for the

Emanuel Tenório Paulino1, Hira Muzammel2, Lucindo José Quintans-Júnior3

  • 1Institute of Pharmaceutical Science, Federal University of Alagoas, Brazil; Unité Nanoregenerative Medicine, Université de Strasbourg, France.

Tissue & Cell
|March 11, 2026
PubMed

Insights

Alpha-terpineol (TPN) promotes heart protection by relaxing coronary arteries and stimulating endothelial cell growth, independent of the endothelium. This compound offers potential in preventing heart damage from reduced oxygen supply.

Area of Science:

  • Cardiovascular Research
  • Pharmacology
  • Molecular Biology

Background:

  • Coronary arteries are vital for heart oxygen and nutrient supply.
  • Myocardial infarction is a prevalent global disease involving ischemia-reperfusion injury.
  • Alpha-terpineol (TPN) has demonstrated cardioprotective effects.

Purpose of the Study:

  • To investigate the vascular effects of alpha-terpineol (TPN) on coronary vessels.
  • To determine if TPN can modulate coronary artery tone and function.

Main Methods:

  • Utilized in vivo, in vitro, and in silico approaches.
  • Included histopathology of coronary arteries, myograph-based perfusion studies, endothelial cell culture, and molecular docking.

Main Results:

  • TPN induced vasorelaxation independently of endothelial presence.
  • TPN promoted endothelial cell growth via nitric oxide (NO) production.
  • TPN demonstrated direct vasodilatory action and restored endothelial cell growth.

Conclusions:

  • TPN modulates vascular function, acting as a vasodilator.
  • TPN can prevent hypoxia/anoxia by ensuring adequate heart perfusion.
  • TPN shows potential for cardioprotection against myocardial infarction.
Abstract

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
6.5K
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
1.8K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
862
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
2.4K
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
1.7K
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
470